marijuana stocks

Cara reports 4Q loss

Cara Therapeutics posts loss of $4.2 million in 4th quarter

SHELTON, Conn. (AP) _ Cara Therapeutics Inc. (CARA) on Thursday reported a fourth-quarter loss of $4.2 million, after reporting a profit in the same period a year earlier.

The Shelton, Connecticut-based company said it had a loss of 18 cents per share.

The biotechnology company posted revenue of $914,000 in the period.

For the year, the company reported that its loss widened to $17.7 million, or 85 cents per share. Revenue was reported as $3.2 million.

Cara shares have fallen nearly 7 percent since the beginning of the year. In the final minutes of trading on Thursday, shares hit $9.30, a drop of 45 percent in the last 12 months.

_____

This story was generated by Automated Insights (https://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on CARA at https://www.zacks.com/ap/CARA

_____

Keywords: Cara Therapeutics, Earnings Report


MAPH Enterprises, LLC | (305) 414-0128 | 1501 Venera Ave, Coral Gables, FL 33146 | new@marijuanastocks.com
Leave a Reply

Your email address will not be published. Required fields are marked *

You May Also Like

Biome Grow Inc. (BIO) (BIOIF) Welcomes Former Ontario Minister of Health, George Smitherman as Senior Vice President

Biome Grow Welcomes Former Ontario Minister of Health, George Smitherman as Senior…

 Next Green Wave Holdings Inc. (NGW) (NXGWF) Acquires Extensive Catalogue of Cannabis Genetics

Next Green Wave Holdings Inc. (CSE: NGW) (OTCQB: NXGWF) (“Next Green Wave” or…

Trulieve Cannabis Corp. (TCNNF) Launches New Innovative Product: Refined Crème

Trulieve Launches New Innovative Product: Refined Crème Trulieve Cannabis Corp. (CSE: TRUL)…

CLS Holdings USA, Inc.’s (CLSH) Oasis Dispensary Featured in February 2019 Edition of A&E Magazine

CLS Holdings’ Oasis Dispensary Featured in February 2019 Edition of A&E Magazine…